RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on April 1 and set a price target of $219.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback